Amazon unveiled its Best Books of 2025 list. Patrick Ryan’s Buckeye claims the No. 1 spot, chosen by the Amazon Editors for its captivating multigenerational storytelling. The top five also include Virginia Evans’ The Correspondent, Nina Willner’s The Boys in the Light,Ocean Vuong’s The Emperor of Gladness, andCharlotte McConaghy’s Wild Dark Shore.
Explore the top 10 picks of 2025 below and discover the full Best Books of the Year list on amazon.com/bestbooks.
Related Posts
Media buyers expect to spend 11.8% more on ads in 2024 -- up 2.3 percentage points from the 9.5% they projected last November. Paid search is forecast to rank third in terms of percentage of growth behind connected television (CTV) and social media.
Four retailers ranked among the top 10 companies in an annual survey of the 100 brands that Americans feel best embody the value of “patriotism."
Levi Strauss & Co., took the fourth spot in brand loyalty and consumer engagement research consultancy Brand Keys' 25th annual “Most Patriotic Brands” survey. Amazon came in sixth, with Walmart and Ralph Lauren taking the seventh and ninth spots respectively. Jeep once again took the top spot. (See end of article for a list of top 20 brands, and all the retailers that cracked the top 100.)
For 2026, the top 20 "most patriotic" brands were:
Jeep
Coca-Cola
Ford
Levi Strauss
Disney
Amazon
Walmart
Hershey’s
Ralph Lauren
Weather Tech
Harley Davidson
ChatGPT
Apple
American Express
Gillette
McDonald’s
Wranger
Jack Daniels
Dunkin’
KFC
By 2032, Eli Lilly will constitute a “league of its own” in worldwide pharma sales, according to researcher Evaluate’s Annual World Preview Report, released June 23.
Lilly’s expected global sales of $137 billion in 2032 will be almost 60% more than that of the second largest pharma firm, AbbVie, Evaluate reports.
The overwhelming success will be driven by Lilly’s weight-loss trio, with Mounjaro at # 1 in sales of all drugs, Zepbound at #3 and Foundayo (its new pill) at #4, according to Evaluate’s forecasts.
Mounjaro and Zepbound together will be worth more than $70 billion, making their common ingredient -- tirzepatide -- into “the biggest drug ever," surpassing Pfizer/BioNTech’s COVID-19 vaccines, Evaluate said.
The three weight loss drugs together “will make up nearly half of total 2032 sales of the top ten best-selling drugs,” per the report.